Any new medical diagnosis can be a lot to process, and atopic dermatitis is no exception. “It can come as quite a shock to suddenly develop eczema as an adult,” says Martin Smith, MD, a double board ...
In an update to the guidelines for managing atopic dermatitis in adults, four new treatment recommendations are presented. The focused update was published online in the Journal of the American ...
Findings showed 16.4% of patients treated with rocatinlimab achieved rIGA success compared with 4.9% of patients who received placebo. Topline results were announced from a phase 3 trial evaluating ...
A session held at the American Academy of Dermatology Annual Meeting 2024 highlighted the ways in which atopic dermatitis can be treated and addressed in adults and older adults. This content was ...
Results of a trial show that tralokinumab is safe, tolerable and effective in older adults to treat moderate to severe atopic dermatitis. The drug is already approved for adults who have the condition ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...
BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma A/S, a global leader in medical dermatology, will present new data and insights in moderate-to-severe atopic dermatitis and chronic hand eczema at the ...
BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma A/S, a global leader in medical dermatology, announces today that it has enrolled the first patients in two new phase 2b clinical studies to investigate ...
Please provide your email address to receive an email when new articles are posted on . Children and adults with atopic dermatitis are 44% and 35% more likely, respectively, to experience inflammatory ...
An artificial intelligence (AI)-enabled hand sensor delivering closed-loop haptic feedback appeared to be an effective nonpharmacologic intervention to decrease nocturnal scratching in patients with ...
Strong recommendations presented for tapinarof cream, roflumilast cream, lebrikizumab, nemolizumab with concomitant topical therapy. HealthDay News — In an update to the guidelines for managing atopic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback